Patient Guide: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 36 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05388474
Status: 🟢 Enrolling Now
Condition: HIV Infections, Multi-Antiviral Resistance
Phase: Not Specified

Where You Can Participate

This study is available at 36 locations across the country.

Top locations include:
  • • Los Angeles, California
  • • Los Angeles, California
  • • Palm Springs, California
  • • And 33 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab - Join Clinical Trial NCTNCT05388474

How to Join This Clinical Trial - NCTNCT05388474

Learn how to participate in this Not Specified trial studying an investigational therapy for HIV Infections, Multi-Antiviral Resistance. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with HIV Infections, Multi-Antiviral Resistance. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
HIV Infections, Multi-Antiviral Resistance
Treatment Being Tested
Investigational treatment
Study Phase
Not Specified - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05388474 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 36 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90036 - United States

Status: TERMINATED

Clinical Research Site

Los Angeles, California 90046 - United States

Status: RECRUITING

Clinical Research Site

Palm Springs, California 92262 - United States

Status: TERMINATED

Clinical Research Site

San Diego, California 92103 - United States

Status: RECRUITING

Clinical Research Site

New Haven, Connecticut 06520 - United States

Status: RECRUITING

Clinical Research Site

Stamford, Connecticut 06850 - United States

Status: TERMINATED

Clinical Research Site

Waterbury, Connecticut 06702 - United States

Status: RECRUITING

Clinical Research Site

Washington, District of Columbia 20005 - United States

Status: RECRUITING

Clinical Research Site

Washington, District of Columbia 20007 - United States

Status: RECRUITING

Clinical Research Site

Fort Lauderdale, Florida 33308 - United States

Status: RECRUITING

And 26 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Not Specified clinical trial for HIV Infections, Multi-Antiviral Resistance:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships